$10.89
Currently 17 wall-street analysts regularly analyze the financials of Amicus Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Amicus Therapeutics, Inc. (FOLD) have a share price target of $15.9. This median of share price forecast represents a 46.01% upside from the latest price of $10.89 as on 16.12.25.
As per the chart shown above, analysts believe that the Amicus Therapeutics, Inc. (FOLD) share price will touch around $15.9 in next 12-months.
Below is a chart showing the percentage difference between Amicus Therapeutics, Inc.'s share price and its median forecast price. As on 16.12.25, the difference is -38.36%
Based on 17 analysts tracking and researching Amicus Therapeutics, Inc. (FOLD) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 8 | 8 | 8 |
| Outperform | 5 | 5 | 5 |
| Hold | 4 | 4 | 4 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |